Your browser doesn't support javascript.
loading
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells.
Scurr, Martin J; Greenshields-Watson, Alex; Campbell, Emma; Somerville, Michelle S; Chen, Yuan; Hulin-Curtis, Sarah L; Burnell, Stephanie E A; Davies, James A; Davies, Michael M; Hargest, Rachel; Phillips, Simon; Christian, Adam D; Ashelford, Kevin E; Andrews, Robert; Parker, Alan L; Stanton, Richard J; Gallimore, Awen; Godkin, Andrew.
Afiliación
  • Scurr MJ; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Greenshields-Watson A; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Campbell E; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Somerville MS; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Chen Y; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Hulin-Curtis SL; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Burnell SEA; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Davies JA; Division of Cancer and Genetics, Sir Geraint Evans Building, Cardiff University, Cardiff, United Kingdom.
  • Davies MM; Department of Colorectal Surgery, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
  • Hargest R; Department of Colorectal Surgery, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
  • Phillips S; Department of Colorectal Surgery, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
  • Christian AD; Department of Histopathology, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
  • Ashelford KE; Division of Cancer and Genetics, Sir Geraint Evans Building, Cardiff University, Cardiff, United Kingdom.
  • Andrews R; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Parker AL; Division of Cancer and Genetics, Sir Geraint Evans Building, Cardiff University, Cardiff, United Kingdom.
  • Stanton RJ; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom.
  • Gallimore A; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom. godkinaj@cardiff.ac.uk gallimoream@cardiff.ac.uk.
  • Godkin A; Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom. godkinaj@cardiff.ac.uk gallimoream@cardiff.ac.uk.
Clin Cancer Res ; 26(13): 3360-3370, 2020 07 01.
Article en En | MEDLINE | ID: mdl-32122920
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis de Secuencia de ARN / Secuenciación de Nucleótidos de Alto Rendimiento / Antígenos de Neoplasias / Neoplasias Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis de Secuencia de ARN / Secuenciación de Nucleótidos de Alto Rendimiento / Antígenos de Neoplasias / Neoplasias Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido